Skip to main content

Advertisement

Log in

Transvascular transcatheter aortic valve implantation in 2017

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Transcatheter aortic valve implantation (TAVI) is emerging as the standard of care for patients with severe aortic stenosis. Recent results have been favourable even for patients with low periprocedural risk.

Methods

We analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing isolated aortic valve replacement in 2017 in Germany, focussing especially on transvascular (TV) TAVI. Patients were stratified according the German Aortic Valve Score (AKL) into the risk classes low, intermediate, high and very high (≥ 10%).

Results

A total of 17,956 TV-TAVI and 9011 isolated surgical aortic valve replacements (iSAVR) were performed in Germany in 2017. Although the total rate of intraprocedural complications after TV-TAVI was the same as in 2016 (both 7.4%), fewer patients experienced an arterial vascular complication in 2017 (2017: 6.0%; 2016: 7.1%; p < 0.001). Likewise, the rate of new pacemaker implantation decreased (2017: 9.6%; 2016:11.4%; p < 0.001). In-hospital mortality after TV-TAVI and iSAVR was equal (2.7%) in 2017, despite the much higher risk profile of TV-TAVI patients. Using the AKL score as reference, TV-TAVI showed a more favourable observed-to-expected mortality (O/E) ratio (0.89) than iSAVR (1.14)- even more pronounced in patients at low risk (0.81 vs. 1.14).

Conclusions

The rates of major complications like bleeding and permanent pacemaker implantation after TV-TAVI keep declining. In 2017 patients undergoing TV-TAVI had a low in-hospital mortality rate with an O/E ratio < 1, indicating that the results were again better than those of all TAVI and SAVR of the previous year.

Graphic abstract

Overall in-hospital mortality after transvascular TAVI and isolated aortic valve repair 2017 in Germany stratified to risk groups by the German Aortic Valve Score (German AV Score/AKL Score): low risk group (AKL 0– < 3%), intermediate risk group (AKL 3– < 6%), high risk group (AKL 6– < 10%) and very high risk group (AKL ≥ 10%)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease The task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European. Eur Heart J 38:2739–2791. https://doi.org/10.1093/eurheartj/ehx391

    Article  PubMed  Google Scholar 

  2. Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L, Tuzcu M, Webb J, Fontana G, Makkar R, Brown D, Block P, Guyton R, Pichard A, Bavaria J, Herrmann H, Douglas P, Peterson J, Akin J, Anderson W, Wand D, Pcocock S, for the PTI (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  CAS  Google Scholar 

  3. Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang D, PS for the PTI (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  CAS  Google Scholar 

  4. Mack MJ, Leon MB, Smith CR et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484. https://doi.org/10.1016/S0140-6736(15)60308-7

    Article  PubMed  Google Scholar 

  5. Thourani VH, Kodali S, Makkar RR et al (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218–2225. https://doi.org/10.1016/S0140-6736(16)30073-3

    Article  PubMed  Google Scholar 

  6. Trenkwalder T, Pellegrini C, Holzamer A et al (2018) Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1364-6

    Article  PubMed  Google Scholar 

  7. Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376:1321–1331. https://doi.org/10.1056/NEJMoa1700456

    Article  PubMed  Google Scholar 

  8. Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620. https://doi.org/10.1056/NEJMoa1514616

    Article  CAS  PubMed  Google Scholar 

  9. Mack M, Leon M, Thourani V et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. https://doi.org/10.1056/nejmoa1814052

    Article  PubMed  PubMed Central  Google Scholar 

  10. Popma J, Deeb G, Yakubov S et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. https://doi.org/10.1056/nejmoa1816885(epub ahead:1–10)

    Article  PubMed  Google Scholar 

  11. Doenst T, Bargenda S, Kirov H et al (2019) Cardiac surgery 2018 reviewed. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01470-6

    Article  PubMed  Google Scholar 

  12. Kim WK, Hamm CW (2018) Transcatheter aortic valve implantation in Germany. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1297-0

    Article  PubMed  Google Scholar 

  13. Frerker C, Bestehorn K, Schlüter M et al (2017) In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany. Clin Res Cardiol 106:610–617. https://doi.org/10.1007/s00392-017-1097-y

    Article  PubMed  Google Scholar 

  14. Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35:1588–1598. https://doi.org/10.1093/eurheartj/eht381

    Article  PubMed  Google Scholar 

  15. Bekeredjian R, Szabo G, Balaban Ü et al (2018) Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J. https://doi.org/10.1093/eurheartj/ehy699

    Article  Google Scholar 

  16. Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve Registry (GARY). J Am Coll Cardiol 65:2173–2180. https://doi.org/10.1016/j.jacc.2015.03.034

    Article  PubMed  Google Scholar 

  17. Mohr FW, Holzhey D, Möllmann H et al (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardio-Thorac Surg 46:808–816. https://doi.org/10.1093/ejcts/ezu290

    Article  Google Scholar 

  18. Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis—complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105:553–559

    Article  Google Scholar 

  19. Gaede L, Blumenstein J, Kim W-K et al (2017) Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair. Clin Res Cardiol 106:411–419. https://doi.org/10.1007/s00392-016-1070-1

    Article  PubMed  Google Scholar 

  20. Gaede L, Kim W-K, Blumenstein J et al (2017) Temporal trends in transcatheter and surgical aortic valve replacement. Herz 42:316–324. https://doi.org/10.1007/s00059-016-4461-1

    Article  CAS  PubMed  Google Scholar 

  21. Gaede L, Blumenstein J, Liebetrau C et al (2018) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J 39:667. https://doi.org/10.1093/eurheartj/ehx688

    Article  PubMed  Google Scholar 

  22. Werner N, Zahn R, Beckmann A et al (2018) Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve implantation for severe symptomatic aortic valve stenosis. One-Year results from the German Aortic Valve Registry. Circulation 138:2611–2623. https://doi.org/10.1161/circulationaha.117.033048

    Article  PubMed  Google Scholar 

  23. Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D (2018) Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. JACC 72:2095–2104. https://doi.org/10.4244/eij-d-17-00584

    Article  PubMed  Google Scholar 

  24. Eggebrecht H, Mehta RH (2016) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11:1029–1033

    Article  Google Scholar 

  25. https://www.iqtig.org/berichte/bundesauswertung/

  26. Kappetein AP, Head SJ, Généreux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60:1438–1454. https://doi.org/10.1016/j.jacc.2012.09.001

    Article  PubMed  Google Scholar 

  27. Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793.e2. https://doi.org/10.1016/j.athoracsur.2009.11.032

    Article  PubMed  Google Scholar 

  28. Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardio-thorac Surg 43:971–977. https://doi.org/10.1093/ejcts/ezt114

    Article  Google Scholar 

  29. Schymik G, Herzberger V, Bergmann J et al (2018) Evolution of transcatheter aortic valve implantation over 7 years: results of a prospective single-centre registry of 2000 patients in a large municipal hospital (TAVIK Registry). BMJ Open 8:e022574. https://doi.org/10.1136/bmjopen-2018-022574

    Article  PubMed  PubMed Central  Google Scholar 

  30. Barbanti M, Capranzano P, Ohno Y et al (2015) Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. EuroIntervention 11:690–697. 10.4244/eijv11i6a137\reijv11i6a137

    Article  Google Scholar 

  31. Urena M, Rodés-Cabau J (2015) Permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8:70–73. https://doi.org/10.1016/j.jcin.2014.09.010

    Article  PubMed  Google Scholar 

  32. Fujita B, Kütting M, Seiffert M et al (2016) Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 17:1385–1393. https://doi.org/10.1093/ehjci/jev343

    Article  PubMed  Google Scholar 

  33. Gaede L, Kim W-K, Liebetrau C et al (2018) Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. https://doi.org/10.1007/s00392-017-1158-2

    Article  PubMed  Google Scholar 

  34. Gonska B, Seeger J, Keßler M et al (2017) Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol. https://doi.org/10.1007/s00392-017-1093-2(epub ahead of print)

    Article  PubMed  Google Scholar 

  35. Erkapic D, De Rosa S, Kelava A et al (2012) Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23:391–397. https://doi.org/10.1111/j.1540-8167.2011.02211.x

    Article  PubMed  Google Scholar 

  36. Mauri V, Deuschl F, Frohn T et al (2018) Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol 107:688–697. https://doi.org/10.1007/s00392-018-1235-1

    Article  PubMed  Google Scholar 

  37. Möllmann H, Hamm CW, Gaede L (2018) European Heart Journal, discussion forum. Eur Heart J. https://doi.org/10.1093/eurheartj/ehy741

    Article  PubMed  Google Scholar 

  38. Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369. https://doi.org/10.1017/CBO9781107415324.004

    Article  CAS  PubMed  Google Scholar 

  39. Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 27:867–874. https://doi.org/10.1017/CBO9781107415324.004

    Article  PubMed  Google Scholar 

  40. Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897. https://doi.org/10.1016/j.amjcard.2012.11.056

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Elizabeth Martinson, PhD, of the KHFI Editorial Office for her editorial assistance. We thank Emilie Hofstetter for her assistance in analysing the data.

Funding

There was no funding for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helge Möllmann.

Ethics declarations

Conflict of interest

Helge Möllmann received speaker honoraria and/or travel grants from Edwards Lifesciences, Abbott, Biotronik, Boston Scientific, St. Jude Medical, Symetis SA. Luise Gaede and Johannes Blumenstein report personal fees from Edwards Lifesciences, Abbott and Boston Scientific. Christian Hamm is advisor to Medtronic. Christoph Liebetrau reports personal fees from Abbott. Holger Nef reports personal fees from Boston Scientific. Won-Keun Kim reports personal fees from Boston Scientific, Abbott, Edwards Lifesciences, Medtronic. All other authors have no conflict of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaede, L., Blumenstein, J., Liebetrau, C. et al. Transvascular transcatheter aortic valve implantation in 2017. Clin Res Cardiol 109, 303–314 (2020). https://doi.org/10.1007/s00392-019-01509-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-019-01509-8

Keywords

Navigation